We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Middleware Boosts Efficiency in Lab Automation

By LabMedica International staff writers
Posted on 03 May 2012
Print article
New middleware for clinical chemistry, microbiology, and molecular biology labs improves laboratory efficiency, compliance, and quality control.

Dubbed Halia, the middleware utilizes a rule-based engine to deliver all-round control over laboratory workflow, and sample processing. The new interface provides a complete web-based lab computerization system, allowing central management and connection of all analyzers through a single interface on any workstation.

Halia’s user-configurable rule-based engine enables autoverification, sample routing, and real-time clinical data capture and management for greater quality control. By supporting open automation systems and addressing issues such as regulatory compliance, workforce reductions, and enhanced quality control, Halia effectively meets the challenges facing lab managers.

Halia instrument middleware from NoemaLife (Bologna, Italy), a European provider of clinical and hospital software solutions, provides a complete lab computerization solution. Halia also provides detailed real-time data on total turnaround time (TAT)–a key performance indicator in large laboratories striving to increase throughput. Halia permits central management of all the pre-analysis, analysis, and post analysis instruments found in a modern clinical lab.

If a Laboratory Information System/Laboratory Information Management System (LIS/LIMS system) goes down, Halia’s LIS/LIMS backup module allows manual input of sample information so that analysis can continue. Manual samples are then matched to LIS/LIMS data once the connection is restored.

Andrea Chiapponi, managing director of NoemaLife SpA, commented, "In addition to laboratories looking for open middleware which is vendor independent, Halia will be of interest to IVD device vendors wanting to create turnkey solutions which include maximum LIS/LIMS connectivity. Halia’s vendor-independence also enables merging of laboratories and even hospitalswith different LIS/LIMS solutions into a seamless wide area network. For example, Halia can manage re-tests on different analyzers deployed in separate labs and coordinate specimen storage information relating to multiple locations."

Related Links:
NoemaLife


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Human Papillomavirus Multiplex Assay
Anyplex Ⅱ HPV28 Detection
New
Anti-Rubella IgG (Rubella IgG) Test
Rubella IgG AccuBind ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The MCED test can screen for up to 42 solid tumors and five hematological tumors (Photo courtesy of 123RF)

Non-Invasive Test Detects Up To 42 Solid Tumors and Five Blood Cancers in Blood and Urine Samples

Cancer is now responsible for nearly 1 in 6 deaths worldwide. Each year, over 14 million people are diagnosed with cancer, and this number is expected to surpass 21 million by 2030. A major issue is that... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The Accelerate WAVE system delivers rapid AST directly from positive blood culture bottles (Photo courtesy of Accelerate Diagnostics)

Rapid Diagnostic System to Deliver Same-Shift Antibiotic Susceptibility Test Results

The World Health Organization estimates that sepsis impacts around 49 million people worldwide each year, resulting in roughly 11 million deaths, with about 1.32 million of these deaths directly linked... Read more

Pathology

view channel
Image: The PAXgene Urine Liquid Biopsy Set is the first standardized preanalytical workflow that stabilizes cell-free DNA in urine for subsequent analysis (Photo courtesy of PreAnalytiX)

Liquid Biopsy Solution Enables Non-Invasive Sample Collection and Direct Cell-Free DNA Stabilization from Urine

Urine cell-free DNA (cfDNA) presents significant potential for research and future clinical applications. It facilitates the measurement and analysis of cfDNA fragments, detection of genetic alterations,... Read more

Industry

view channel
Image: International expert meeting for trends and innovations in laboratory medicine - the MEDICA LABMED FORUM at MEDICA (Photo courtesy of Constanze Tillmann/Messe Düsseldorf)

MEDICA LABMED FORUM 2024: International Experts Meet to Discuss Trending Topics in Laboratory Medicine

At MEDICA (Düsseldorf, Germany), the world’s premier trade fair for the healthcare industry and medical technology sector, this year’s event (November 11–14) will focus on the most exciting medical advancements.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.